Here are the most recently published webpages on our site with information related to your search.
If you want to search CCSA publications, please use the advanced Publication Search.
This issue is the second of a special two-part series. Part 2 examines key factors driving stimulant use, what these trends mean for different groups of people and the responses being implemented to reduce harms.
Three key points of…
As global leaders and experts gather in Vienna this week for the 69th session of the Commission on Narcotic Drugs, the Permanent Mission of Canada to the United Nations in Vienna and the Canadian Centre on Substance Use and Addition (CCSA) co-…
With almost 100 people in attendance, we co-hosted the Concurrent Disorders Virtual Summit in early February 2026 with Homewood Research Institute (HRI). Insights from participants are helping improve integrated care for people living with…
To help improve how we treat individuals with concurrent disorders, a prioritization exercise with experts from across Canada was conducted during the Concurrent Disorders Think Tank in December 2024. The event was co-hosted by CCSA and Homewood…
February 10, 2026 (Ottawa) — New data reveal the number of people who used cannabis at least once in the past year has increased by approximately…
The Canadian Centre on Substance Use and Addiction (CCSA) proudly welcomes…
Susan Russell-Csanyi brings both professional expertise and lived experience to her work in substance use, addiction and social advocacy.
Substance use can significantly impact the workplace through lost productivity, low morale and safety concerns. Through prevention, education, changing workplace cultures and developing comprehensive policies, employers can help reduce the…
Highlights key information on Cannabinoid Hyperemesis Syndrome (CHS) in Canada, an underrecognized condition that is linked to frequent cannabis use and exposure to high-THC products and can result in repeated episodes of severe nausea, vomiting…
